|
|
||||||||
Division of Medical Imaging, Department of Radiology, and Division of Cardiology, Department of Internal Medicine, at the University of Virginia Health Sciences Center, Charlottesville, Virginia
Department of Nuclear Medicine, Hotel-Dieu de Montreal, Montreal, Canada
Correspondence: For reprints contact: Denny D. Watson, Nuclear Cardiology, Box 468-65, University of Virginia Health Sciences Center, Charlottesville, VA 22908.
ABSTRACT
Sestamibi planar myocardial perfusion studies were performed at Hotel-Dieu de Montreal on 28 patients with documented coronary artery disease and 16 normal subjects. Stress and rest studies were performed on separate days. These studies were sent to Virginia for interpretation while blinded as to age, sex, and other clinical information. Studies were quantitated independently by two operators (using a computer program modified for Sestamibi), and interpreted independently by two experienced interpreters. Computer quantitation of 2816 segments gave an average interoperator deviation of 2.2%. Pure quantitative criteria were applied for computer interpretation. By varying the detection threshold, we produced the entire ROC curve relating sensitivity and specificity as a function of detection threshold. Using only computer criteria for normal or abnormal, interoperator agreement by patient was 98% and 93% by view. The computer could achieve equal positive and negative predictive accuracy of 87%. Interpreters, allowed both quantitative and subjective judgment, agreed on 91% of 44 patients, 90% of 132 views, and 92% of 660 segments. Interpreters averaged 94% positive and 86% negative predictive accuracy.
This article has been cited by other articles:
![]() |
D. D. Miller The Growing Flood of Technetium-99m Myocardial Perfusion Agents : More Water . . . or More Mud? Circulation, January 15, 1995; 91(2): 555 - 558. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |